44 Results for "

CDC7

" in MedChemExpress (MCE) Product Catalog:
Products (44)

44 Results for "CDC7" in MCE Product Catalog:

Cat. No.: HY-143377
CAS No.: 2606780-38-3
Target:  

CDK

Research Areas:  

Cancer

Cdc7-IN-8 is a potent inhibitor of Cdc7. Cdc7 is a serine/threonine kinase which activates MCM promotion by phosphorylating the microchromosome maintenance protein (MCM protein), an important element of the DNA replication initiator. Cdc7-IN-8 has the potential for the research of cancer diseases (extracted from patent WO2021032170A1, compound 1-1/1-2) .
loading...
    loading...
Cat. No.: HY-143432A
CAS No.: 2562329-13-7
Target:  

CDK

Research Areas:  

Cancer

(S)-Cdc7-IN-18 is a potent inhibitor of CDC7. Overexpression of huCdc7 promotes overactivation of MCM2, an important marker of tumor cells, and thus promotes aberrant proliferation of tumor cells. (S)-Cdc7-IN-18 has the potential for the research of cancer diseases (extracted from patent WO2020239107A1, compound 1-1) .
loading...
    loading...
Cat. No.: HY-143429
CAS No.: 1244027-03-9
Target:  

CDK

Research Areas:  

Cancer

Cdc7-IN-15 (Example 108) is a cdc7 kinase inhibitor. Cdc7-IN-15 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-143387
CAS No.: 2764866-23-9
Target:  

CDK

Research Areas:  

Cancer

Cdc7-IN-13 (compound 84) is a potent CDC7 inhibitor with an IC50 of <1 nM. Cdc7-IN-13 has the potential for the research of cancer .
loading...
    loading...
Cat. No.: HY-143389
CAS No.: 2764866-21-7
Target:  

CDK

Research Areas:  

Cancer

Cdc7-IN-14 (compound 82) is a potent CDC7 inhibitor with an IC50 of <1 nM. Cdc7-IN-14 has the potential for the research of cancer .
loading...
    loading...
Cat. No.: HY-143385
CAS No.: 2764865-33-8
Target:  

CDK

Research Areas:  

Cancer

Cdc7-IN-12 (compound 1) is a potent CDC7 inhibitor with an IC50 of <1 nM. Cdc7-IN-12 shows antiproliferative activities with IC50 of 100-1000 nM in COLO205 cells. Cdc7-IN-12 has the potential for the research of cancer .
loading...
    loading...
Cat. No.: HY-143432
CAS No.: 2562329-14-8
Target:  

CDK

Research Areas:  

Cancer

Cdc7-IN-18 (compound 1-2) is a potent CDC7 inhibitor with an IC50 of 1.29 nM for Cdc7/DBF4 enzyme. Cdc7-IN-18 shows antiproliferative activities with IC50 of 53.62 nM in COLO205 cells .
loading...
    loading...
Cat. No.: HY-117677
CAS No.: 1330781-04-8
Target:  

CDK

Research Areas:  

Cancer

Cdc7-IN-21 (compound 10c) is a potent and selective Cdc7 inhibitor with an IC50 of 0.07 nM. Cdc7-IN-21 can be used to study cancer .
loading...
    loading...
Cat. No.: HY-143380
CAS No.: 2649407-21-4
Target:  

CDK

Research Areas:  

Cancer

Cdc7-IN-9 is a potent Cdc7 inhibitor and can be used for cancer research .
loading...
    loading...
Cat. No.: HY-130515
CAS No.: 1402057-87-7
Target:  

CDK

Research Areas:  

Cancer

Cdc7-IN-3 (compound I-A) is a potent Cdc7 kinase inhibitor extracted from patent WO2019165473A1, compound I-B. Cdc7 is a serine-threonine protein kinase enzyme which is essential for the initiation of DNA replication in the cell cycle .
loading...
    loading...
Cat. No.: HY-130517
CAS No.: 1402057-86-6
Purity:  96.73%
Target:  

CDK

Research Areas:  

Cancer

Cdc7-IN-5 (compound I-B) is a potent Cdc7 kinase inhibitor extracted from patent WO2019165473A1, compound I-B. Cdc7 is a serine-threonine protein kinase enzyme which is essential for the initiation of DNA replication in the cell cycle .
loading...
    loading...
Cat. No.: HY-130516
CAS No.: 1402059-21-5
Target:  

CDK

Research Areas:  

Cancer

Cdc7-IN-4 (compound I-C) is a potent Cdc7 kinase inhibitor extracted from patent WO2019165473A1, compound I-C. Cdc7 is a serine-threonine protein kinase enzyme which is essential for the initiation of DNA replication in the cell cycle .
loading...
    loading...
Cat. No.: HY-E70650
Target:  

CDK

Research Areas:  

Cancer

CDC7/DBF4 Recombinant Human Active Protein Kinaseis a protein kinase that is required for the initiation of DNA replication in eukaryotes .
loading...
    loading...
Cat. No.: HY-162007
Target:  

CDK

Research Areas:  

Cancer

PYRA-2 is a CDC7 kinase inhibitor with potential for cancer research .
loading...
    loading...
Cat. No.: HY-101523R
CAS No.: 1402055-25-7
Target:  

CDK Reference Standards

Research Areas:  

Cancer

Cdc7-IN-1 (Standard) is the analytical standard of Cdc7-IN-1 (HY-101523). This product is intended for research and analytical applications. Cdc7-IN-1 (Compound 13) is a highly potent, selective and ATP competitive inhibitor of Cdc7 kinase, with an IC50 value of 0.6 nM at 1 mM ATP and with slow off-rate characteristics. Cdc7-IN-1 potently inhibits Cdc7 activity in cancer cells, and effectively induces cell death .
loading...
    loading...
Cat. No.: HY-143430
CAS No.: 1627696-52-9
Target:  

CDK

Research Areas:  

Cancer

(S)-LY3177833 ((S)-Example 2) is an orally active CDC7 kinase inhibitor. (S)-LY3177833 shows broad in vitro anticancer activity .
loading...
    loading...
Cat. No.: HY-143430A
CAS No.: 2733342-93-1
Target:  

CDK

Research Areas:  

Cancer

(S)-LY3177833 ((S)-Example 2) hydrate is an orally active CDC7 kinase inhibitor. (S)-LY3177833 hydrate shows broad in vitro anticancer activity .
loading...
    loading...
Cat. No.: HY-P81407
Synonyms: CDC7 ; CDC7L1; Cell division cycle 7-related protein kinase; CDC7-related kinase; HsCDC7; huCDC7

Host:  

Rabbit

Application:  

IHC-P

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P81407A
Synonyms: CDC7 ; CDC7L1; Cell division cycle 7-related protein kinase; CDC7-related kinase; HsCDC7; huCDC7

Host:  

Rabbit

Application:  

IHC-P

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P88036

Host:  

Rabbit

Application:  

WB, FC

Reactivity:  

Human, Mouse, Rat

loading...
    loading...